CH640639A5 - Verfahren zur herstellung eines spezifischen immunserums. - Google Patents

Verfahren zur herstellung eines spezifischen immunserums. Download PDF

Info

Publication number
CH640639A5
CH640639A5 CH373178A CH373178A CH640639A5 CH 640639 A5 CH640639 A5 CH 640639A5 CH 373178 A CH373178 A CH 373178A CH 373178 A CH373178 A CH 373178A CH 640639 A5 CH640639 A5 CH 640639A5
Authority
CH
Switzerland
Prior art keywords
serum
iap
specific immune
cancer
producing
Prior art date
Application number
CH373178A
Other languages
German (de)
English (en)
Inventor
Yoshiji Matsuda
Keiji Tamura
Hiroaki Motoki
Fumio Kitame
Nakao Ishida
Original Assignee
Saikin Kagaku Kenkyujo Kk
Kayaku Antibiotic Research Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saikin Kagaku Kenkyujo Kk, Kayaku Antibiotic Research Co filed Critical Saikin Kagaku Kenkyujo Kk
Publication of CH640639A5 publication Critical patent/CH640639A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH373178A 1977-06-16 1978-04-06 Verfahren zur herstellung eines spezifischen immunserums. CH640639A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7134977A JPS548714A (en) 1977-06-16 1977-06-16 Production of specific antiserum

Publications (1)

Publication Number Publication Date
CH640639A5 true CH640639A5 (de) 1984-01-13

Family

ID=13457921

Family Applications (1)

Application Number Title Priority Date Filing Date
CH373178A CH640639A5 (de) 1977-06-16 1978-04-06 Verfahren zur herstellung eines spezifischen immunserums.

Country Status (7)

Country Link
US (1) US4269765A (2)
JP (1) JPS548714A (2)
CA (1) CA1093964A (2)
CH (1) CH640639A5 (2)
DE (1) DE2814121C3 (2)
FR (1) FR2394805A1 (2)
GB (1) GB1565333A (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56132563A (en) * 1980-03-21 1981-10-16 Terumo Corp Reagent for testing biological material and use thereof
JPS56142459A (en) * 1980-04-08 1981-11-06 Terumo Corp Living substance inspecting method and container therefore
US4447545A (en) * 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
JPS62135297U (2) * 1986-02-20 1987-08-26
JPS62161494U (2) * 1986-04-01 1987-10-14
JPS6344592U (2) * 1986-09-08 1988-03-25

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388284B (sv) * 1969-12-18 1976-09-27 Kowa Co Gelmedium for diagnos av primert hepatom medelst immundiffusion eller elektrofores
US3819822A (en) * 1969-12-18 1974-06-25 Kowa Co Diagnostic agent for detection of primary hepatoma
GB1291134A (en) * 1970-01-21 1972-09-27 Anvar A process for the production of mammal cell anti-sera
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
GB1388719A (en) * 1971-09-02 1975-03-26 Hadassah Medical Relief Ass In Pure t-globulin and its anti-serum
FR2222084B1 (2) * 1973-03-22 1976-05-14 Fontaine Michel
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm

Also Published As

Publication number Publication date
CA1093964A (en) 1981-01-20
GB1565333A (en) 1980-04-16
JPS548714A (en) 1979-01-23
US4269765A (en) 1981-05-26
FR2394805A1 (fr) 1979-01-12
DE2814121A1 (de) 1978-12-21
JPS6118699B2 (2) 1986-05-14
DE2814121B2 (de) 1979-10-04
DE2814121C3 (de) 1980-06-26
FR2394805B1 (2) 1980-08-08

Similar Documents

Publication Publication Date Title
DE2902676C2 (de) Verfahren zur Analyse eines von RF oder C1q verschiedenen Antigens im Serum mittels eines Immunoassays
DE2639623A1 (de) Mittel und verfahren zur neoplasmadiagnose
DE2816841A1 (de) Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
DE1598945A1 (de) Verfahren zur Bestimmung von Proteinen und Polypeptiden
DE2548636A1 (de) Antiseren und antikoerper mit spezifischer wirkung gegen krebszellenproteine, verfahren zu ihrer herstellung und arzneipraeparate
EP0013930B1 (de) Immunogen, Antikörper für ein Thymus-Hormon, markiertes Thymus-Hormon und Verfahren zur Bestimmung dieses Thymushormons
DE2952478A1 (de) Verfahren und mittel zur immunologischen bestimmung von enzymen
DE3205301C2 (2)
CH640639A5 (de) Verfahren zur herstellung eines spezifischen immunserums.
DE3022681A1 (de) Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten
DE1767899A1 (de) Verfahren zur Isolierung von Antigenen und Antikoerpern
DE2934757C2 (de) Zusammensetzung und Verfahren zur Bestimmung von Humanimmunglobulin-G
DE2714751C2 (2)
EP0165476A2 (de) Gewebeprotein PP18, Verfahren zu seiner Gewinnung sowie seine Verwendung
CH645727A5 (de) Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung.
DE1617734B1 (de) Verfahren zur Herstellung eines immunologischen Reagens
DE2742835A1 (de) Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis
Weissmann et al. Turbidity produced by hexamminecobaltic chloride in serum of rabbits injected intravenously with papain.
DE3915344A1 (de) Serumdiagnose-verfahren
EP0068291B1 (de) Immunochemisches Verfahren und Testkit zur Bestimmung der sauren Prostataphosphatase
DD214000A5 (de) Verfahren zur bestimmung von igg
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
EP0013306B1 (de) Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins
DE2333740A1 (de) Antigen, verfahren zu dessen isolierung, bestimmung und dessen verwendung
DE1617734C (de) Verfahren zur Herstellung eines immunologischen Reagens

Legal Events

Date Code Title Description
PL Patent ceased